You are here

  • Home
  • Archive
  • Volume 7, Issue 5
  • The Taking Charge After Stroke (TaCAS) study protocol: a multicentre, investigator-blinded, randomised controlled trial comparing the effect of a single Take Charge session, two Take Charge sessions and control intervention on health-related quality of l…

Article Text

Article menu

Download PDFPDF

XML
Rehabilitation medicine
Protocol
The Taking Charge After Stroke (TaCAS) study protocol: a multicentre, investigator-blinded, randomised controlled trial comparing the effect of a single Take Charge session, two Take Charge sessions and control intervention on health-related quality of life 12 months after stroke for non-Māori, non-Pacific adult New Zealanders discharged to community living
  1. Vivian Wai Yin Fu1,
  2. Mark Weatherall2,
  3. Harry McNaughton1
  1. 1 Medical Research Institute of New Zealand, Wellington, New Zealand
  2. 2 University of Otago, Wellington, New Zealand
  1. Correspondence to Dr Vivian Wai Yin Fu; vivian.fu{at}mrinz.ac.nz

Abstract

Introduction Stroke is one of the leading causes of disability worldwide. Recent data support the possibility that person-centred, self-management interventions can reduce dependence after stroke. However, there is limited information on the generalisability and optimum dose of these interventions.

Methods The Taking Charge After Stroke (TaCAS) study is a multicentre, investigator-blinded, randomised controlled trial recruiting 400 participants following acute stroke from seven hospitals in New Zealand. All patients discharged to community living who have ongoing symptoms at time of discharge (modified Rankin scale>0) will be eligible. Participants will be randomly assigned to one Take Charge session, two Take Charge sessions 6 weeks apart or control.

Outcomes The primary outcome will be the Physical Component Summary score of the Short-Form 36 at 12 months post stroke. Secondary outcomes will include dependence (modified Rankin scale), performance in activities of daily living (Barthel Index) and carer strain (Caregiver Strain Index), at 6 and 12 months post stroke. All analyses will be conducted on an intention-to-treat basis.

Ethics and dissemination The TaCAS study is funded by a Health Research Council of New Zealand grant. It has been approved by the Central Health and Disability Ethics Committee (15/CEN/115). Results will be published and presented at relevant stroke meetings within New Zealand and internationally, informing the use of a self-management intervention after stroke.

Trial registration Australia and New Zealand Clinical Trials Registry ACTRN12615001163594. Date registered 02-11-2015. Medical Research Institute of New Zealand Registry TCS01. Universal trial number U1111-1171-4127.

  • Stroke
  • Rehabilitation
  • Self-management

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/bmjopen-2017-016512

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors HM conceived the study. HM, VF and MW contributed to the study design. VF collected the data. HM, VF and MW will be responsible for data analysis and interpretation. VF drafted this protocol, and HM and MW contributed equally to its critical review. VF, MW and HM have given final approval of this version to be published.

    • Funding This work was supported by the Health Research Council (HRC) of New Zealand (grant 15/297). The HRC had no role in the preparation or decision to publish of this protocol.

    • Competing interests None declared.

    • Ethics approval New Zealand Health and Disability Ethics Committee.

    • Provenance and peer review Not commissioned; externally peer reviewed.